Pre-Conference Courses and Workshops

  • Recommend
  • Tweet
  • Print
  • Email

Executive Presentation Workshop

Learn to effectively communicate your technology, products or services and how best to position your company to potential partners, customers and investors. Develop an effective slide show and learn how to deliver a memorable presentation. Attendees will have the chance to speak with leading business-development executives who will share their insights on how you can present your company most effectively.

Business Development Basics Course

This course is an introductory-level course designed for professionals new to the life sciences business development field, or for individuals with some experience and who are interested in updating their knowledge and professional skills. Many participants who may already have some experience in licensing or business development will take this course as a refresher.

Supporting Organization: 

November 11, 2013
Beijing location to be announced

Preliminary Agenda and Topics Covered:

  • Opening Remarks
  • Concept and Importance of Business Development in Life Sciences
  • Technology Transfer with Academic Institutes
  • Break
  • Key Elements of Business Development
  • Lunch
  • Deal Sourcing, Asset Evaluation and Due Diligence
  • Anatomy of a Deal Term Sheet
  • Break
  • Deal Negotiation and Contracts
  • Legal Aspect of Deal Making

This course will be taught by skilled industry professionals who have extensive hands-on experience in licensing. Instructors to be announced.

Regulatory/Policy Workshop

BIO will host a regulatory policy workshop on the sidelines of the BIO Convention in China with relevant government stakeholders. Past workshops with CFDA have included issues related to clinical trials in China and global regulatory harmonization, while others have included SIPO patent examiners on the nuances of biotechnology patents. As new topics arise in 2013, BIO plans to engage CFDA on issues related to the development of an official biosimilars regulatory pathway and new developments in clinical trial regulations.